Potential role for rFVIIa in transfusion medicine

被引：173

作者：

Hedner, U ^{[1
]}

Erhardtsen, E ^{[1
]}

机构：

[1] Novo Nordisk AS, Res & Dev, DK-2880 Bagsvaerd, Denmark

来源：

关键词：

D O I：

10.1046/j.1537-2995.2002.00017.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：114 / 124

页数：11

共 85 条

[1] ABERG M, 1978, ANN SURG, V189, P243
[2] ALTERATIONS IN COAGULATION AND FIBRINOLYTIC MECHANISMS IN ACUTE TRAUMA
ATTAR, S
BOYD, D
LAYNE, E
MCLAUGHLIN, J
MANSBERGER, AR
COWLEY, RA
[J]. JOURNAL OF TRAUMA, 1969, 9 (11): : 939 - +
[3] EXPRESSION OF TISSUE FACTOR PROCOAGULANT ACTIVITY - REGULATION BY CYTOSOLIC CALCIUM
BACH, R
RIFKIN, DB
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (18) : 6995 - 6999
[4] PURIFICATION AND CHARACTERIZATION OF TAFI, A THROMBIN-ACTIVABLE FIBRINOLYSIS INHIBITOR
BAJZAR, L
MANUEL, R
NESHEIM, ME
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) : 14477 - 14484
[5] BAUER KA, 1990, BLOOD, V76, P731
[6] BECH R, 1989, THROMB HAEMOSTASIS, V62, P55
[7] Beguin S, 1997, THROMB HAEMOSTASIS, V78, P590
[8] BEGUIN S, 1989, THROMB HAEMOSTASIS, V61, P25
[9] Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: A preliminary study
Bernstein, DE
Jeffers, L
Erhardtsen, E
Reddy, KR
Glazer, S
Squiban, P
Bech, R
Hedner, U
Schiff, ER
[J]. GASTROENTEROLOGY, 1997, 113 (06) : 1930 - 1937
[10] NovoSeven® in warfarin-treated patients
Berntorp, E
Stigendal, L
Lethagen, S
Olofsson, L
Hedner, U
[J]. BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 : S113 - S115